Chengjuan Zhang Selected Research

Chengjuan Zhang Research Topics

Disease

18	Neoplasms (Cancer) 01/2023 - 12/2015
4	Stomach Neoplasms (Stomach Cancer) 05/2024 - 01/2020
4	Lung Neoplasms (Lung Cancer) 01/2021 - 12/2015
3	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2020
3	Esophageal Squamous Cell Carcinoma 01/2023 - 01/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2018 - 12/2015
2	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 01/2019
2	Liver Neoplasms (Liver Cancer) 10/2021 - 01/2019
2	Colonic Neoplasms (Colon Cancer) 09/2021 - 10/2020
2	Breast Neoplasms (Breast Cancer) 01/2019 - 03/2016
1	Carcinogenesis 10/2022
1	Dyspepsia (Indigestion) 01/2022
1	Esophagitis 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 10/2021
1	Microcephaly 10/2021
1	Colitis-Associated Neoplasms 09/2021
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Adenocarcinoma of Lung 05/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2020
1	Hyperlipidemias (Hyperlipidemia) 01/2020
1	Obesity 01/2020
1	Tetraploidy 02/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2015

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2015
3	Phosphotransferases (Kinase)IBA 01/2023 - 12/2015
3	ErbB Receptors (EGF Receptor)IBA 02/2018 - 12/2015
2	Granzymes (Granzyme)IBA 01/2023 - 01/2021
2	sulphorapheneIBA 01/2023 - 01/2019
2	PerforinIBA 01/2023 - 01/2021
2	ProteomeIBA 01/2023 - 01/2019
2	Monoclonal AntibodiesIBA 01/2023 - 01/2021
2	Long Noncoding RNAIBA 10/2022 - 01/2019
2	Messenger RNA (mRNA)IBA 10/2022 - 03/2016
2	Interleukin-2 (IL2)IBA 01/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2020
2	Gefitinib (Iressa)FDA Link 02/2018 - 12/2015
1	camrelizumabIBA 05/2024
1	isoliquiritigenin (GU 17)IBA 01/2023
1	Pentamidine (NebuPent)FDA LinkGeneric 01/2023
1	CholesterolIBA 01/2023
1	PPAR gammaIBA 01/2023
1	MitogensIBA 01/2023
1	AntacidsIBA 01/2022
1	oxethazaineIBA 01/2022
1	AmidesIBA 01/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Aurora Kinase AIBA 01/2022
1	CateninsIBA 10/2021
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 09/2021
1	Xanthine DehydrogenaseIBA 09/2021
1	atezolizumabIBA 01/2021
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	CytokinesIBA 01/2021
1	CollagenIBA 10/2020
1	alpha2 Subunit Collagen Type IIBA 10/2020
1	Caspase 3 (Caspase-3)IBA 10/2020
1	Pyruvate KinaseIBA 05/2020
1	Keratins (Keratin)IBA 01/2020
1	Procaterol (Pro-Air)IBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	p21-Activated KinasesIBA 01/2020
1	xanthohumolIBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2019
1	6- (5- ((cyclopropylamino)carbonyl)- 3- fluoro- 2- methylphenyl)- N- (2,2- dimethylprpyl)- 3- pyridinecarboxamideIBA 02/2018
1	Small Interfering RNA (siRNA)IBA 02/2018
1	Tyrosine Kinase InhibitorsIBA 07/2017
1	Phenobarbital (Luminal)FDA Link 03/2016
1	2- (4- (4- methoxyphenoxy)- 1H- pyrazol- 3- yl)- 5- (p- tolylmethoxy)phenolIBA 12/2015
1	Gemcitabine FDA Link 12/2015
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2015

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2019
4	Immunotherapy 01/2023 - 01/2019
3	Drug Therapy (Chemotherapy) 05/2024 - 01/2021
1	Neoadjuvant Therapy 05/2024
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Oral Administration 01/2020
1	Combination Drug Therapy (Combination Chemotherapy) 12/2015